Manager
GESIURIS ASSET MANAGEMENT, SGIIC, S.A.
See the CNMV manager universe →
Fund page
GESIURIS PATRIMONIAL, FI
Category
—
Latest period
H2 2025
Positions
70
Portfolio as of 2025-12-31. Source: periodic filing with the CNMV. View original filing (PDF)
Full portfolio
Every position in the latest periodic filing, largest weight first. Aggregates ("other equities...") are baskets of small positions the filing itself does not break out line by line.
70
Company
Type
Country
Weight
Price
This period's moves
H2 2025 vs H1 2025 (estimated)
New: 26
Exits: 27
Increases: 17
Cuts: 2
+ ACCIONES|DEUTSCHE BOERSE AG
Enters the portfolio at 0.56% weight.
Deutsche Börse AG operates as an international exchange organization in Germany, rest of Europe, the United States, and the Asia-Pacific. The company operates through four segments: Investment Management Solutions, Trading & Clearing, Fund Services, and Securities Services. The Investment Management Solutions segment offers financial data, analytics, and software-as-a-service solutions including research, data collection, data analysis, and the provision of indices, analytics and investment management software to institutional investors, banks, and corporate clients. The Trading & Clearing segment engages in the development and operation of markets and trading systems for securities, derivatives, commodities, currencies, digital assets, and other asset classes. This segment handles settlement of transactions through clearing houses. Its Fund Services segment provides infrastructure and services for fund processing, including order routing, settlement, custody, data and distribution support for investment funds. The Securities Services segment offers various services for securities issuance, settlement, custody as well as collateral, securities lending, and liquidity management. The company was founded in 1585 and is headquartered in Eschborn, Germany.
View company page →− NESTLE HOLDING INC
Leaves the portfolio; it was 3.59% of weight.
− DEUDA ESTADO USA
Leaves the portfolio; it was 3.08% of weight.
− ACCIONES|REPSOL SA
Leaves the portfolio; it was 2.65% of weight.
− CITIGROUP INC
Leaves the portfolio; it was 1.97% of weight.
− REPSOL INTL FINANCE
Leaves the portfolio; it was 1.97% of weight.
− MEDTRONIC GBLHOLDING
Leaves the portfolio; it was 1.95% of weight.
− PORSCHE
Leaves the portfolio; it was 1.70% of weight.
− BANK OF AMERICA
Leaves the portfolio; it was 1.30% of weight.
− ACCIONES|ASML HOLDING NV
Leaves the portfolio; it was 1.11% of weight.
− ACCIONES|DEUTSCHE TELEKOM AG
Leaves the portfolio; it was 1.02% of weight.
− ACCIONES|AIRBUS GROUP NV
Leaves the portfolio; it was 0.99% of weight.
Airbus SE, together with its subsidiaries, engages in the design, manufacture, and delivery of aeronautics and aerospace products, services, and solutions worldwide. It operates through three segments: Airbus, Airbus Helicopters, and Airbus Defence and Space. The Airbus segment develops, manufactures, markets, and sells commercial jet passenger aircraft, freighter aircraft, regional turboprop aircraft, and aircraft components, as well as provides aircraft conversion and related services. The Airbus Helicopters segment develops, manufactures, markets, and sells civil and military helicopters; and provides uncrewed aerial systems and their related services. The Airbus Defence and Space segment designs, develops, delivers, and supports crewed and uncrewed military air systems and related services. This segment also offers civil and defence space systems for telecommunications, earth observations, navigation, and science and orbital systems; and services around data processing from platforms, secure communication, and cyber security. The company was formerly known as Airbus Group SE and changed its name to Airbus SE in April 2017. The company was incorporated in 1998 and is headquartered in Leiden, the Netherlands.
View company page →− ACCIONES|SAMSUNG ELECTRONICS
Leaves the portfolio; it was 0.98% of weight.
− ABERTIS
Leaves the portfolio; it was 0.98% of weight.
− METROVACESA
Leaves the portfolio; it was 0.97% of weight.
− CIE AUTOMOTIVE SA
Leaves the portfolio; it was 0.97% of weight.
− CIE AUTOMOTIVE SA
Leaves the portfolio; it was 0.95% of weight.
− ACCIONA
Leaves the portfolio; it was 0.95% of weight.
− INMOB.COLONIAL, S.A.
Leaves the portfolio; it was 0.94% of weight.
− ACCIONES|JOHNSON & JOHNSON
Leaves the portfolio; it was 0.94% of weight.
− ACCIONES|TESLA MOTORS INC
Leaves the portfolio; it was 0.88% of weight.
− ACCIONA
Leaves the portfolio; it was 0.65% of weight.
− ACCIONES|EDP RENOVAVEIS SA
Leaves the portfolio; it was 0.44% of weight.
− AT&T INC
Leaves the portfolio; it was 0.33% of weight.
− VIDRALA SA
Leaves the portfolio; it was 0.33% of weight.
− ALMIRALL LABORATORIO
Leaves the portfolio; it was 0.32% of weight.
− GLOBAL DOMINION
Leaves the portfolio; it was 0.32% of weight.
− ACCIONES|HALOZYME THERAPEUTIC
Leaves the portfolio; it was 0.28% of weight.
▲ ACCIONES|GRIFOLS
Goes from 1.70% to 2.75%.
Grifols, S.A., together with its subsidiaries, engages in the research, development, production, and marketing of plasma-derived medicines in the United States, Canada, Spain, Europe, and internationally. It operates through four segments: Biopharma, Diagnostic, Bio Supplies, and Others. The company offers various hemoderivatives from human plasma for immunology, infectious diseases, hepatology, intensive care, pulmonology, hematology, and neurology treatment areas; and markets diagnostic testing equipment, reagents, and other equipment, as well as provides transfusion medicine, clinical diagnostics, and testing services. It also offers biological products, including albumin, albumin-derived products, immunoglobulins, thrombin, other proteins, and intermediate plasma products to pharma and biotech companies for biopharma use; and whole blood, blood components, processed plasma, and clinical samples to life-science research and in-vitro diagnostic companies for diagnostic use. In addition, the company provides healthcare solutions for hospitals, such as intravenous solutions to maintain or restore fluids and electrolyte balance in patients; high-tech solutions to automate hospital processes; clinical nutrition to deliver nutrition and medication; and medical devices comprising instrumentation and disposable materials for various hospital services, which include interventional neuroradiology, hemodynamics, urology, anesthesiology and cardiovascular surgery, as well as manufacturing services to third parties and research activities. Further, it is involved in engineering services; packaging, labelling, storage, distribution, manufacturing, and development of pharmaceutical products; import, export, and commercialization activities; travel agency services; reinsurance of insurance policies; support services; law business; and consultation, administration, and financing services. The company was founded in 1909 and is headquartered in Barcelona, Spain.
View company page →▲ ACCIONES|VIATRIS INC
Goes from 0.54% to 1.11%.
Viatris Inc., together with its subsidiaries, operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East. It operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The company offers prescription brand drugs, generic drugs, complex generic drugs, and biosimilars. It also provides drugs in various therapeutic areas covering various noncommunicable and infectious diseases, including cardiovascular, CNS and anesthesia, dermatology, diabetes and metabolism, eye care, gastroenterology, immunology, oncology, and respiratory and allergy, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. In addition, the company offers medicines in the form of oral solid doses, injectables, and complex dosage forms to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions. It distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies under the Lyrica, Lipitor, Celebrex, Viagra, Creon, Influvac, Wixela Inhub, EpiPen Auto-Injector, Fraxiparine, Yupelri, Norvasc, Amitiza, Effexor, Lipacreon, Zoloft, Xalabrands, Dymista, Xanax, and Breyna brands. The company has collaboration agreements with Mapi Pharma Ltd. to develop and commercialize long-acting glatiramer acetate depot products and additional products; Revance Therapeutics, Inc. to develop, manufacture, and commercialize a biosimilar to the branded biologic product, BOTOX; and Theravance Biopharma, Inc. to develop and commercialize revefenacin. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania.
View company page →Fixed income
Declared FI exposure
15.0 M €
% of portfolio
53.3%
Positions
40
Issuers
34
Sovereign: 0 €
Corporate: 15.0 M €
Maturity ladder
Observed contractual maturity of each position, repos excluded. Matured/≤3 months includes bonds maturing in the first days after the period close.
Matured or ≤3 months · 7.2%3-6 months · 3.9%6-12 months · 37.2%1-2 years · 23.7%2-5 years · 28.1%
Maturity
Positions
Exposure
%
Matured or ≤3 months
3
1.1 M €
7.2%
3-6 months
4
591,678 €
3.9%
6-12 months
13
5.6 M €
37.2%
1-2 years
9
3.5 M €
23.7%
2-5 years
11
4.2 M €
28.1%
5-10 years
0
0 €
0.0%
> 10 years
0
0 €
0.0%
Unknown
0
0 €
0.0%
Top issuers
The 10 issuers with the largest declared exposure in this fund, repos excluded.
Issuer
Type
ISINs
Exposure
Next maturity
BNP PARIBAS SA
Corporate
2
1.2 M €
2027-01-23
MORGAN STANLEY
Corporate
1
1.2 M €
2027-03-19
NETFLIX INC
Corporate
2
1.1 M €
2026-11-15
J.P.MORGAN
Corporate
1
1.1 M €
2026-10-01
MOODY´S CORP
Corporate
2
1.0 M €
2027-03-09
ARCELOR MITTAL
Corporate
1
723,566 €
2026-09-26
AMGEN INC
Corporate
1
682,250 €
2026-02-25
GOLDMAN SACHS
Corporate
1
596,589 €
2026-07-27
NASDAQ INC
Corporate
1
570,559 €
2029-03-28
HERA SPA
Corporate
1
490,505 €
2026-10-14
Top instruments
The 10 instruments with the largest declared exposure. No yield, IRR or rating: there's no reliable data to compute them.
ISIN
Coupon
Maturity
Exposure
XS2790333616 MORGAN STANLEY
2.70%
2027-03-19
1.2 M €
US46625HRV41 J.P.MORGAN
2.95%
2026-10-01
1.1 M €
XS2537060746 ARCELOR MITTAL
4.88%
2026-09-26
723,566 €
XS2010038227 MOODY´S CORP
0.95%
2030-02-25
720,358 €
US64110LAN64 NETFLIX INC
4.38%
2026-11-15
683,376 €
XS1369278764 AMGEN INC
2.00%
2026-02-25
682,250 €
FR001400CFW8 BNP PARIBAS SA
3.63%
2029-09-01
611,524 €
FR0013398070 BNP PARIBAS SA
2.13%
2027-01-23
598,151 €
XS1458408561 GOLDMAN SACHS
1.63%
2026-07-27
596,589 €
XS1843442622 NASDAQ INC
1.75%
2029-03-28
570,559 €
Currencies
Fixed-income exposure by instrument currency.
Currency
Exposure
%
EUR
12.7 M €
84.9%
USD
2.3 M €
15.1%
This period's fixed-income moves
Compares the current fixed-income portfolio with the previous period, by ISIN. An exit that coincides with maturity isn't a sale: the bond reached its contractual date.
New positions: 23
Exits at maturity: 14
Exits not explained by maturity: 4
+ GOLDMAN SACHS
Enters the portfolio at 2.12% weight.
+ ENEL SPA
Enters the portfolio at 1.47% weight.
+ ACCIONA
Enters the portfolio at 1.39% weight.
+ MASTERCARD INC
Enters the portfolio at 1.34% weight.
+ ABERTIS
Enters the portfolio at 1.11% weight.
+ L´OREAL SA
Enters the portfolio at 1.07% weight.
+ MOODY´S CORP
Enters the portfolio at 1.06% weight.
+ BARCELO CORP EMPRESA
Enters the portfolio at 1.04% weight.
+ PROSEGUR CASH
Enters the portfolio at 1.04% weight.
+ INMOB.COLONIAL, S.A.
Enters the portfolio at 1.02% weight.
+ MCDONALD´S CORP
Enters the portfolio at 0.90% weight.
+ PROCTER & GAMBLE CO
Enters the portfolio at 0.90% weight.
+ COCA-COLA HBC FINANC
Enters the portfolio at 0.72% weight.
+ GRIFOLS
Enters the portfolio at 0.70% weight.
+ METROVACESA
Enters the portfolio at 0.70% weight.
+ AFRICAN DEVELOPMENT
Enters the portfolio at 0.70% weight.
+ GESTAMP AUTOMOCION S
Enters the portfolio at 0.69% weight.
+ CAIXABANK SA
Enters the portfolio at 0.36% weight.
+ BMW INTL INVEST BV
Enters the portfolio at 0.36% weight.
+ GLOBAL DOMINION
Enters the portfolio at 0.35% weight.
+ GLOBAL DOMINION
Enters the portfolio at 0.35% weight.
+ CIE AUTOMOTIVE SA
Enters the portfolio at 0.35% weight.
+ GESTAMP AUTOMOCION S
Enters the portfolio at 0.35% weight.
− CITIGROUP INC
Leaves the portfolio; it was 1.97% of weight.
− PORSCHE
Leaves the portfolio; it was 1.70% of weight.
− BANK OF AMERICA
Leaves the portfolio; it was 1.30% of weight.
− ALMIRALL LABORATORIO
Leaves the portfolio; it was 0.32% of weight.
◦ NESTLE HOLDING INC
Leaves the portfolio; it was 3.59% of weight.
◦ DEUDA ESTADO USA
Leaves the portfolio; it was 3.08% of weight.
◦ REPSOL INTL FINANCE
Leaves the portfolio; it was 1.97% of weight.
◦ MEDTRONIC GBLHOLDING
Leaves the portfolio; it was 1.95% of weight.
◦ ABERTIS
Leaves the portfolio; it was 0.98% of weight.
◦ METROVACESA
Leaves the portfolio; it was 0.97% of weight.
◦ CIE AUTOMOTIVE SA
Leaves the portfolio; it was 0.97% of weight.
◦ CIE AUTOMOTIVE SA
Leaves the portfolio; it was 0.95% of weight.
◦ ACCIONA
Leaves the portfolio; it was 0.95% of weight.
◦ INMOB.COLONIAL, S.A.
Leaves the portfolio; it was 0.94% of weight.
◦ ACCIONA
Leaves the portfolio; it was 0.65% of weight.
◦ AT&T INC
Leaves the portfolio; it was 0.33% of weight.
◦ VIDRALA SA
Leaves the portfolio; it was 0.33% of weight.
◦ GLOBAL DOMINION
Leaves the portfolio; it was 0.32% of weight.
Disclaimer
This is not financial advice. The portfolio comes from the periodic report the fund files with the CNMV and lags the real close of the period: it is a snapshot of the end of each half-year, not a real-time portfolio.